High cortisol and low folate are the only routine blood tests predicting probable alzheimer's disease after age 75 - Results of the vienna transdanube aging study

Journal of the American Geriatrics Society

Volumn 61, Issue 4, 2013, Pages 648-651

  Hinterberger, Margareta ^a   Zehetmayer, Sonja ^b   Jungwirth, Susanne ^a   Huber, Klaus ^c   Leitha, Thomas ^c   Krampla, Wolfgang ^c   Tragl, Karl Heinz ^a   Fischer, Peter ^a,c  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c DANUBE HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ANDROSTENEDIONE; APOLIPOPROTEIN E; C REACTIVE PROTEIN; CORTICOTROPIN; CYANOCOBALAMIN; ESTRADIOL; FERRITIN; FIBRINOGEN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; HYDROCORTISONE; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROGESTERONE; PROLACTIN; TESTOSTERONE; THYROTROPIN; TRANSFERRIN; TRIACYLGLYCEROL;

AGED; ALLELE; ALZHEIMER DISEASE; CHOLESTEROL BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DSM-IV; ESTRADIOL BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; FIBRINOGEN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; FOLLOW UP; GERIATRIC DEPRESSION SCALE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; LETTER; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; TRANSFERRIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; AUSTRIA; COHORT STUDIES; CONFIDENCE INTERVALS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; FOLIC ACID; HEMATOLOGIC TESTS; HOMOCYSTEINE; HUMANS; HYDROCORTISONE; LONGITUDINAL STUDIES; MALE; ODDS RATIO; PROGNOSIS; RISK FACTORS;

EID: 84876264530     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12178     Document Type: Letter

References (10)

1. Daviglus ML, Plassman BL, Pirzada A, et al. Risk factors and preventive interventions for Alzheimer disease: State of the science. Arch Neurol 2011; 68: 1185-1190.
2. Fischer P, Zehetmayer S, Jungwirth S, et al. Risk factors for Alzheimer dementia in a community-based birth cohort at the age of 75 years. Dement Geriatr Cogn Disord 2008; 25: 501-507.
3. Fischer P, Jungwirth S, Krampla W, et al. Vienna Transdanube Aging VITA: Study design, recruitment strategies and level of participation. J Neural Transm 2002; 62 (Suppl): 103-116.
4. Fischer P, Jungwirth S, Hinterberger M, et al. Reversible Alzheimer's disease. J Am Geriatr Soc 2011; 59: 1137-1138.
5. Stetler C, Miller GE,. Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosom Med 2011; 73: 114-126.
6. Dotson VM, Beydoun MA, Zonderman AB,. Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 2010; 75: 27-34.
7. Lee BK, Glass TA, Wand GS, et al. Apolipoprotein E genotype, cortisol and cognitive function in community dwelling older adults. Am J Psychiatry 2008; 165: 1456-1464.
8. Karlamangla AS, Singer BH, Chodosh J, et al. Urinary cortisol excretion as a predictor of incident cognitive impairment. Neurobiol Aging 2005; 26 (Suppl 1): 80-84.
9. Rothman SM, Mattson MP,. Adverse stress, hippocampal networks and Alzheimer' disease. NeuroMol Med 2010; 12: 56-70.
10. Hinterberger M, Fischer P,. Folate and Alzheimer: When time matters. J Neural Transm 2013; 120: 211-224.